Context Therapeutics Inc. (CNTX) stock
CNTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.17+0.01 (+3.07%)
Close on Nov 17, 2026Market cap $15.71MP/E –Yield –
Context Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Context Therapeutics's price to book ratio was 0.5× on Nov 11, 2026, against 1.4× a year earlier. Over the last 5 years it ranged from 0.3× to 5.0×, with a median of 0.8×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.5× | −1.3 |
| 2025 | Dec 31, 2025 | 1.8× | +0.9 |
| 2024 | Dec 31, 2024 | 0.9× | −0.0 |
| 2023 | Dec 29, 2023 | 1.0× | +0.7 |
| 2022 | Dec 30, 2022 | 0.3× | – |
See a number that looks wrong?